STOK•benzinga•
Stoke Therapeutics Q4 2024 GAAP EPS $(0.18) Beats $(0.53) Estimate, Sales $22.60M Beat $4.28M Estimate
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 18, 2025 by benzinga